Artrya
Artrya Limited is a cutting-edge medical technology company specializing in software that automates the analysis of heart CT scans to aid in the diagnosis of Coronary Artery Disease. Positioned as an innovator in healthcare AI solutions, Artrya focuses on providing accurate, non-invasive diagnostic tools that enhance patient care outcomes. Their offerings are particularly valuable in improving the detection efficiency and accuracy of coronary artery disease assessments.
Short position
Artrya (ASX:AYA) has 8.55% of its shares on issue reported as short positions as of 5 Oct 2026, or about 13,978,278 shares. Over the past 30 days that figure has risen 6.19 percentage points, and over 90 days it has risen 7.64 percentage points. AYA is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Artrya (AYA) company profile
Profile, insiders and operations
Company
AI-generated research profile of Artrya
AYA intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links